Go offline with the Player FM app!
GLP 1s - One Class of Drugs with Many Different Names
Manage episode 476909269 series 3331397
In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman go head-to-head in a friendly face-off between two of the most talked-about medications in diabetes and weight management: Ozempic and Mounjaro. Both are part of the powerful GLP-1 class, but which one might be better for you? From A1C reduction and weight loss to heart and kidney protection, ease of use, side effects, and insurance coverage—Drs. E & P walk you through a category-by-category comparison. They bring the clinical data and their own real-world patient experience to help you understand the key differences (and similarities) between these leading therapies. Whether you're managing type 2 diabetes, living with type 1, or exploring options for weight loss, this episode is designed to help you make an informed decision with your healthcare provider.
Key Topics:
- How These Medications Work: Learn the difference between GLP-1 and dual agonist therapies
- A1C Reduction: See which drug leads to greater blood sugar improvements based on head-to-head clinical trials.
- Weight Loss: Discover how much weight patients lose on each medication—and why Mounjaro often shows stronger results.
- Heart Health: Understand which medication has FDA approval for cardiovascular protection and what’s still under investigation.
- Kidney Protection: Explore the latest studies showing Ozempic’s ability to slow kidney disease progression.
- Side Effects: Get practical tips on managing common GI side effects and why titration matters.
- Ease of Use: Compare how the pens work, dosing flexibility, and what may be easier for patients day to day.
- Sleep Apnea: Find out how Mounjaro earned a new indication for reducing sleep apnea severity—especially through weight loss.
- Access for Type 1s: Learn why these meds aren’t yet approved for T1D and how some patients are still getting them.
- Emerging Indications: Hear about new uses for these meds, including fatty liver, osteoarthritis, and even alcohol reduction.
- How to Choose: Get expert guidance on which medication may be right for you based on your goals and health needs.
74 episodes
Manage episode 476909269 series 3331397
In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman go head-to-head in a friendly face-off between two of the most talked-about medications in diabetes and weight management: Ozempic and Mounjaro. Both are part of the powerful GLP-1 class, but which one might be better for you? From A1C reduction and weight loss to heart and kidney protection, ease of use, side effects, and insurance coverage—Drs. E & P walk you through a category-by-category comparison. They bring the clinical data and their own real-world patient experience to help you understand the key differences (and similarities) between these leading therapies. Whether you're managing type 2 diabetes, living with type 1, or exploring options for weight loss, this episode is designed to help you make an informed decision with your healthcare provider.
Key Topics:
- How These Medications Work: Learn the difference between GLP-1 and dual agonist therapies
- A1C Reduction: See which drug leads to greater blood sugar improvements based on head-to-head clinical trials.
- Weight Loss: Discover how much weight patients lose on each medication—and why Mounjaro often shows stronger results.
- Heart Health: Understand which medication has FDA approval for cardiovascular protection and what’s still under investigation.
- Kidney Protection: Explore the latest studies showing Ozempic’s ability to slow kidney disease progression.
- Side Effects: Get practical tips on managing common GI side effects and why titration matters.
- Ease of Use: Compare how the pens work, dosing flexibility, and what may be easier for patients day to day.
- Sleep Apnea: Find out how Mounjaro earned a new indication for reducing sleep apnea severity—especially through weight loss.
- Access for Type 1s: Learn why these meds aren’t yet approved for T1D and how some patients are still getting them.
- Emerging Indications: Hear about new uses for these meds, including fatty liver, osteoarthritis, and even alcohol reduction.
- How to Choose: Get expert guidance on which medication may be right for you based on your goals and health needs.
74 episodes
All episodes
×
1 What Sets these Diabetes Devices Apart and More Importantly What Device Is Uniquely Right For YOU in 2025, with David Ahn, MD 41:03

1 GLP 1s - One Class of Drugs with Many Different Names 34:43

1 A Groundbreaking Therapy with Tzield Ft. Special Guest Sierra Werling 34:13

1 Unlocking the Mystery of Type 1 Diabetes – The TEDDY & Cascade Studies with Michael Killiam 33:52

1 Diabetes and Fatty Liver Disease with Dr. Juan Pablo Frias 33:58

1 The Link Between the Heart and the Kidneys: Cardiovascular Kidney Metabolic Syndrome 38:18

1 Diabetes and Exercise with former NBA Player Gary Forbes 35:18

1 Top 10 Lifestyle Tips for Better Diabetes Management in the New Year! 32:01


1 Diabetes-Related Musculoskeletal Issues (Trigger Finger, Frozen Shoulder, Arthritis and Other Musculoskeletal Issues) 34:01

1 Breathing and Meditation, with Dr. Preethika Ekanayake, Clinical Endocrinologist, UCSD 29:22

1 The Link between Diabetes and Certain Types of Cancers, with Radiation Oncologist Dr. David Diamond 30:49

1 Eye Health, with Ophthalmology Specialist, Nikolas London, MD 31:53


1 A Sit Down with Breakthrough T1D's (Formerly JDRF) CEO Aaron Kowalski 34:44
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.